POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether an oral medication called dasatinib could help control several rare blood cancers and disorders. Sixty-eight adults with conditions like acute myeloid leukemia, myelofibrosis, and mastocytosis took the pill daily for as long as it worked. Researchers mea…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo tested for aggressive blood cancers
Disease control CompletedThis study tested a combination of two drugs, ruxolitinib and CPX-351, for people with advanced forms of certain blood cancers. The main goals were to find the safest dose of the combination and to see how well it worked to control the disease. The treatment aimed to reduce cance…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Gentler transplant strategy tested for tough blood cancers
Disease control CompletedThis study tested a two-step, lower-intensity stem cell transplant for patients with high-risk blood cancers like leukemia and lymphoma. The goal was to control the cancer by first using low-dose chemotherapy and radiation to prepare the body, then infusing donor stem cells to at…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug tested for tough blood cancer cases
Disease control CompletedThis study tested a drug called itacitinib for people with a serious bone marrow cancer called myelofibrosis who had already tried other standard treatments. The main goals were to find a safe dose and see if the drug could reduce spleen size and improve symptoms. Only four peopl…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC